Nucleoside reverse transcriptase inhibitor (NRTI)
Selection of Resistance in Protease Inhibitor-Experienced, Human Immunodeficiency Virus Type 1-Infected Subjects Failing Lopinavir- and Ritonavir-Based Therapy: Mutation Patterns and Baseline Correlates
10
Switch rates, time to switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital claim database
11
Phylogenetic and Genetic Analysis of Feline Immunodeficiency Virus gag, pol, and env Genes from Domestic Cats Undergoing Nucleoside Reverse Transcriptase Inhibitor Treatment or Treatment-Naïve Cats in Rio de Janeiro, Brazil
12
FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ZIDOVUDINE USING SUBLIMATION TECHNIQUE
13
Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus – 1 (HIV-1) infected pediatric patients: a cross-sectional study
7
Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1
9
Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1 patient exposed to efavirenz for three weeks: a case report and review of the literature
5
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies
13
<p>Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data</p>
10
Volume 2 | Issue 4 - 2012
5
AN INSIGHT TO STRUCTURAL ANALYSIS OF COUMARINS AS NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
18
"A REVIEW ON PATHOLOGY OF AIDS AND ITS TREATMENT REGIMENS" by Nadeem Siddiqui*, Waquar Ahsan, Priya Ahuja, M. Shamsher Alam, Anwar Habib, India.
11
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
6
Comparative Study of Various Non-Nucleoside Reverse Transcriptase Inhibitors on Different Reverse Transcriptase Enzyme
7
Post-exposure prophylaxis for non-occupational exposure to HIV: experience in NSW one year after the introduction of the guidelines
5
Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
10
Nonnucleoside Reverse Transcriptase Inhibitor-Resistant HIV Is Stimulated by Efavirenz during Early Stages of Infection
13
The impact of a UK HIV-1 resistance database for the management and improvement of the clinical care of people living with HIV-1
238
Human Immunodeficiency Virus Type 1: Resistance to Nucleoside Analogues and Replicative Capacity in Primary Human Macrophages
11
Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders
10